Thromboembolic Events in Severe COVID-19 Patients

• Conditions: Pulmonary Thromboembolism

• Registration Number: NCT04405869
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

The main objective of this study is to describe the incidence of thromboembolic events in a population of patients hospitalized in intensive care units in France for severe COVID-19. The secondary objective of this study is to describe the evolution of hemostasis parameters during the first two weeks of intensive care hospitalization and to evaluate the influence of different anticoagulation regimens on these parameters and on the incidence of thromboembolic events

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-29
• Status Verified: 2020-05
• Study First Submitted: 2020-05-25
• Study First Submitted QC: 2020-05-27
• Last Update Submitted: 2020-05-27
• Study First Posted: 2020-05-28
• Last Update Posted: 2020-05-29
• Primary Completion: 2021-04
• Study Completion: 2021-04

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Confirmed infection with the Sars-CoV-2 virus (RT-PCR)
• Hospitalization in Intensive Care Unit
• Age over 18 years Old

Exclusion Criteria

• Refusal of the patient to participate in data collection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Analysis of incidence of thromboembolic events in patients with Sars-CoV-2	1 month

Trial Locations

Locations (1)

Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil; 🇫🇷 Strasbourg, France